A novel NF- B inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors
- 15 March 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (6), 2324-2331
- https://doi.org/10.1182/blood-2004-08-3247
Abstract
Constitutive phosphorylation of c-kit tyrosine kinase is the major cause of factor-independent proliferation of mast cells. Recently available tyrosine kinase inhibitors have shown marked activity against mast cell lines that carry wild-type c-kit, and some, but not others, carry mutant c-kit. Here we clearly demonstrated that a novel NF-κB inhibitor, IMD-0354, restrained factor-independent proliferation of mast cells with c-kit mutations but not of normal mast cells. In HMC-1 cells with the Asp816Val and Val560Gly mutations, we found that NF-κB was constitutively activated without exogenous stimulation. When the DNA-binding activity of NF-κB was inhibited by treatment with IMD-0354, cell proliferation was completely suppressed. We detected the expression of cyclin D2, D3, and E in HMC-1 cells and observed that cyclin D3 expression was dramatically decreased by treatment with IMD-0354. Abolishing protein kinase C or phosphatidylinositol 3 kinase pathways also inhibited NF-κB translocation to the nucleus, indicating the involvement of these signaling cascades in NF-κB activation in HMC-1 cells. Our findings indicated that autophosphorylated c-kit receptors induced NF-κB activation, resulting in the up-regulation of cyclin D3 expression and cell cycle progression. The observations from the current study suggest a therapeutic potential, in systemic mastocytosis, for compounds that interfere with NF-κB signaling.Keywords
This publication has 34 references indexed in Scilit:
- Expression of Cyclin E Renders Cyclin D-CDK4 Dispensable for Inactivation of the Retinoblastoma Tumor Suppressor Protein, Activation of E2F, and G1-S Phase ProgressionPublished by Elsevier BV ,2004
- Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinasesOncogene, 2003
- STI571 inhibits growth and adhesion of human mast cells in cultureJournal of Leukocyte Biology, 2003
- NF-κB-dependent Induction of Cyclin D1 by Retinoblastoma Protein (pRB) Family Proteins and Tumor-derived pRB MutantsPublished by Elsevier BV ,2003
- MastocytosisCurrent Opinion in Allergy and Clinical Immunology, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- NF-κB and cell-cycle regulation: the cyclin connectionCytokine & Growth Factor Reviews, 2001
- Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit PhosphorylationScience, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998